Wilkinson presented an interesting review in which the authors discussed the effectiveness of nonablative therapy for Meniere’s disease (MD). Based on their experience and on their review of the literature, the authors concluded that clinicians should consider nonablative therapies before intratympanic (IT) administration of gentamicin or surgical procedures, that they suggested only in the minority of subjects, as widely reported in literature. The article is very interesting and the vast experience of a historical department like the House Ear Institute should be always considered. However, we would like to point out some short remarks.

Therapeutic options in Meniere's disease: our experience / De Luca, P.; Cassandro, C.; Ralli, M.; Di Stadio, A.; Viola, P.; Cassandro, E.; Scarpa, A.. - In: AMERICAN JOURNAL OF OTOLARYNGOLOGY. - ISSN 0196-0709. - (2021). [10.1016/j.amjoto.2021.102939]

Therapeutic options in Meniere's disease: our experience

Ralli M.;Di Stadio A.;
2021

Abstract

Wilkinson presented an interesting review in which the authors discussed the effectiveness of nonablative therapy for Meniere’s disease (MD). Based on their experience and on their review of the literature, the authors concluded that clinicians should consider nonablative therapies before intratympanic (IT) administration of gentamicin or surgical procedures, that they suggested only in the minority of subjects, as widely reported in literature. The article is very interesting and the vast experience of a historical department like the House Ear Institute should be always considered. However, we would like to point out some short remarks.
2021
antisecretory factory; Intratympanic gentamicin; Intravenous glycerol; Meniere's disease
01 Pubblicazione su rivista::01f Lettera, Nota
Therapeutic options in Meniere's disease: our experience / De Luca, P.; Cassandro, C.; Ralli, M.; Di Stadio, A.; Viola, P.; Cassandro, E.; Scarpa, A.. - In: AMERICAN JOURNAL OF OTOLARYNGOLOGY. - ISSN 0196-0709. - (2021). [10.1016/j.amjoto.2021.102939]
File allegati a questo prodotto
File Dimensione Formato  
De Luca_Therapeutic options_2021.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 273.7 kB
Formato Adobe PDF
273.7 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1524848
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact